Page last updated: 2024-08-21

alpha-aminopyridine and tofacitinib

alpha-aminopyridine has been researched along with tofacitinib in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	7 (87.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Opar, A	1
Regens, AL; Yazici, Y	1
Fleischmann, R	1
Steiger, B; Yazici, Y	1
Burmester, GR; Feist, E	1
Dholakia, S; Fildes, JE; Friend, PJ	1
Bonnel, D; Eriksson, AH; Legouffe, R; Mortensen, RW; Nielsen, KT; Pamelard, F; Stauber, J	1
Lé, AM; Torres, T	1

Reviews

6 review(s) available for alpha-aminopyridine and tofacitinib

Article	Year
Promising new treatments for rheumatoid arthritis - the kinase inhibitors. Bulletin of the NYU hospital for joint diseases, 2011, Volume: 69, Issue:3 Topics: Aminopyridines; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Intracellular Signaling Peptides and Proteins; Janus Kinases; Morpholines; Oxazines; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Syk Kinase; Treatment Outcome	2011
Novel small-molecular therapeutics for rheumatoid arthritis. Current opinion in rheumatology, 2012, Volume: 24, Issue:3 Topics: Aminopyridines; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Janus Kinases; Molecular Targeted Therapy; Morpholines; Oxazines; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles	2012
Kinase inhibitors for the treatment of rheumatoid arthritis. Bulletin of the NYU hospital for joint diseases, 2012, Volume: 70, Issue:3 Topics: Aminopyridines; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Morpholines; Oxazines; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Signal Transduction; Treatment Outcome	2012
Small molecules targeting JAKs--a new approach in the treatment of rheumatoid arthritis. Rheumatology (Oxford, England), 2013, Volume: 52, Issue:8 Topics: Administration, Oral; Aminopyridines; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Forecasting; Germany; Humans; Janus Kinases; Male; Maximum Tolerated Dose; Molecular Targeted Therapy; Morpholines; Oxazines; Piperidines; Prognosis; Pyridines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome	2013
The use of kinase inhibitors in solid organ transplantation. Transplantation reviews (Orlando, Fla.), 2017, Volume: 31, Issue:3 Topics: Aminopyridines; Humans; Immunosuppressive Agents; Indoles; Morpholines; Organ Transplantation; Oxazines; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Sunitinib; Syk Kinase	2017
New Topical Therapies for Psoriasis. American journal of clinical dermatology, 2022, Volume: 23, Issue:1 Topics: Administration, Topical; Aminopyridines; Amygdalin; Benzamides; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dermatologic Agents; Humans; Interleukin-2; MicroRNAs; Nitriles; Phosphodiesterase 4 Inhibitors; Piperidines; Psoriasis; Pyrazoles; Pyrimidines; Resorcinols; Stilbenes	2022

Other Studies

2 other study(ies) available for alpha-aminopyridine and tofacitinib

Article	Year
Kinase inhibitors attract attention as oral rheumatoid arthritis drugs. Nature reviews. Drug discovery, 2010, Volume: 9, Issue:4 Topics: Administration, Oral; Aminopyridines; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Delivery Systems; Drug Design; Humans; Morpholines; Oxazines; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles	2010
MALDI imaging facilitates new topical drug development process by determining quantitative skin distribution profiles. Analytical and bioanalytical chemistry, 2018, Volume: 410, Issue:11 Topics: Acetamides; Administration, Topical; Aminopyridines; Benzamides; Cyclopropanes; Drug Discovery; Humans; Nitriles; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Skin; Skin Absorption; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2018

Article

Year

Kinase inhibitors attract attention as oral rheumatoid arthritis drugs.

Nature reviews. Drug discovery, 2010, Volume: 9, Issue:4

Topics: Administration, Oral; Aminopyridines; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Delivery Systems; Drug Design; Humans; Morpholines; Oxazines; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles

2010

MALDI imaging facilitates new topical drug development process by determining quantitative skin distribution profiles.

Analytical and bioanalytical chemistry, 2018, Volume: 410, Issue:11

Topics: Acetamides; Administration, Topical; Aminopyridines; Benzamides; Cyclopropanes; Drug Discovery; Humans; Nitriles; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Skin; Skin Absorption; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2018